World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
54
Citations
10027
World Ranking
4935
National Ranking
2214

Overview

Carrie K. Jones is affiliated with Vanderbilt University in the United States. Their research spans multiple fields within the life sciences, emphasizing biochemical and molecular mechanisms involved in neuroscience and pharmacology. Their work frequently addresses receptor mechanisms and signaling pathways, especially those related to acetylcholine receptors and their role in neurological and neuropsychiatric disorders.

The main fields of study for this scientist include Biochemistry, Genetics and Molecular Biology, with 55 publications, and Neuroscience, with 37 publications. Within these broader areas, they have contributed notably to several subfields:

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Cognitive Neuroscience
  • Genetics
  • Pharmacology

Their primary topics of research encompass:

  • Receptor Mechanisms and Signaling
  • Neuroscience and Neuropharmacology Research
  • Nicotinic Acetylcholine Receptors Study
  • Memory and Neural Mechanisms
  • Pharmacological Receptor Mechanisms and Effects
  • Neurotransmitter Receptor Influence on Behavior
  • Cholinesterase and Neurodegenerative Diseases

Carrie K. Jones has published extensively in various scientific journals. Frequent publication venues include:

  • Alzheimer's & Dementia (8 publications)
  • ACS Chemical Neuroscience (4 publications)
  • Journal of Medicinal Chemistry (3 publications)
  • ACS Medicinal Chemistry Letters (3 publications)
  • American Journal of Geriatric Psychiatry (2 publications)

Their recent publications reflect active engagement with research on muscarinic acetylcholine receptors and neuropharmacological approaches to substance use and neurodevelopmental disorders. Notable recent papers include:

  • "Acetylcholine Muscarinic M4 Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents," 2020, Biological Psychiatry
  • "Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders," 2020, Genes Brain & Behavior
  • "Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder," 2022, Journal of Medicinal Chemistry
  • "M 1 -selective muscarinic allosteric modulation enhances cognitive flexibility and effective salience in nonhuman primates," 2023, Proceedings of the National Academy of Sciences
  • "Modulation of arousal and sleep/wake architecture by M1 PAM VU0453595 across young and aged rodents and nonhuman primates," 2020, Neuropsychopharmacology

The scientist collaborates frequently with other researchers in their field. Regular co-authors include:

  • Craig W. Lindsley (29 joint publications)
  • P. Jeffrey Conn (14 joint publications)
  • Michael Bubser (12 joint publications)
  • Colleen M. Niswender (11 joint publications)
  • Sichen Chang (11 joint publications)

Best Publications

  • Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia

    P. Jeffrey Conn;Craig W. Lindsley;Craig W. Lindsley;Carrie K. Jones

  • Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders

    P. Jeffrey Conn;Carrie K. Jones;Craig W. Lindsley;Craig W. Lindsley

  • Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats

    Carrie K. Jones;Ashley E. Brady;Albert A. Davis;Zixiu Xiang

  • Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

    Carrie K Jones;Nellie Byun;Michael Bubser

  • Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.

    Alice L. Rodriguez;Mark D. Grier;Carrie K. Jones;Elizabeth J. Herman

  • Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.

    Colleen M. Niswender;Kari A. Johnson;C. David Weaver;Carrie K. Jones

  • Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats

    Ashley E. Brady;Carrie K. Jones;Thomas M. Bridges;J. Phillip Kennedy

  • The Role of Estrogen in Brain and Cognitive Aging

    Jason K Russell;Carrie K Jones;Paul A Newhouse

  • Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.

    Ruggero Galici;Carrie K. Jones;Kamondanai Hemstapat;Yi Nong

  • Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents.

    Carrie K. Jones;Steven C. Peters;Harlan E. Shannon

  • Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function

    Meredith J. Noetzel;Jerri M. Rook;Paige N. Vinson;Hyekyung P. Cho

  • Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents

    Michael Bubser;Thomas M Bridges;Thomas M Bridges;Ditte Dencker;Robert W Gould

  • Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release

    Daniel J. Foster;Jermaine M. Wilson;Daniel H. Remke;M. Suhaib Mahmood

  • A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.

    Douglas J. Sheffler;Richard Williams;Thomas M. Bridges;Zixiu Xiang

  • Muscarinic Receptor Pharmacology and Circuitry for the Modulation of Cognition

    Michael Bubser;Nellie Byun;Michael R. Wood;Carrie K. Jones

  • The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease

    Carrie K. Jones;Michael Bubser;Analisa D. Thompson;Jonathan W. Dickerson

  • Biased mGlu5-positive allosteric modulators provide in vivo efficacy without potentiating mGlu5 modulation of NMDAR currents

    Jerri M. Rook;Zixiu Xiang;Xiaohui Lv;Ayan Ghoshal

  • Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.

    Thomas M. Bridges;Joy E. Marlo;Colleen M. Niswender;Carrie K. Jones

  • Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100.

    Nellie E Byun;Michael Grannan;Michael Bubser;Robert L Barry

  • Muscarinic Cholinergic Modulation of Prepulse Inhibition of the Acoustic Startle Reflex

    Carrie K. Jones;Harlan E. Shannon

  • Novel Allosteric Agonists of M1 Muscarinic Acetylcholine Receptors Induce Brain Region-Specific Responses That Correspond with Behavioral Effects in Animal Models

    G. J. Digby;M. J. Noetzel;M. Bubser;T. J. Utley

Frequent Co-Authors

Colleen M. Niswender
Colleen M. Niswender Vanderbilt University
Michael Bubser
Michael Bubser Vanderbilt University
Nicholas J. Brandon
Nicholas J. Brandon Neumora Therapeutics Inc
Danny G. Winder
Danny G. Winder Vanderbilt University
Robert M. Kessler
Robert M. Kessler University of Alabama at Birmingham
Joseph T. Coyle
Joseph T. Coyle Harvard University
Ariel Y. Deutch
Ariel Y. Deutch Vanderbilt University
Yoland Smith
Yoland Smith Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Carrie K. Jones

Trending Scientists